RESEARCH SUMMARY

Dr. Gabriela Bravo Montenegro works with Dr. Ramaprasad Srinivasan developing precision, targeted treatment strategies and clinical trials for patients with both hereditary and non-hereditary forms of kidney cancer. Currently, they are investigating a variety of mechanism-based treatment strategies in clear cell and papillary kidney cancer, as well as hereditary kidney cancer syndromes such as von Hippel-Lindau, hereditary leiomyomatosis and renal cell cancer (HLRCC) and hereditary papillary renal cell cancer (HPRC).

Areas of Expertise